Acute kidney injury (AKI) is estimated to occur in up to 50% of patients with liver cirrhosis and is associated with increased morbidity and a high risk of short-term and long-term mortality.1 ...

A groundbreaking study shows that GLP-1 agonist anti-obesity drugs not only aid weight loss but significantly improve ...

The popular painkiller Advil has been increasingly targeting the running community, partnering with influencers to promote ...

From hot dogs and potato chips to chicken nuggets and sugary sodas, Americans are eating more ultra-processed foods (UPFs) ...

A new study has demonstrated that iron deficiency (ID) is significantly associated with an increased risk of kidney failure, ...

A rare kidney transplant, the surgery was performed on a patient with chronic kidney disease that began with a hypertension ...

People taking the drugs had a lower risk of organ failure and death However, the drugs were associated with an increased risk ...

Patients with T2D who undergo kidney transplants are less likely to experience organ failure and mortality if they receive ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.

GLP-1 receptor agonists were initially approved for glycaemic control in type 2 diabetes and, subsequently, for bodyweight loss in obesity. Following large-scale trials demonstrating that some GLP-1 ...

The Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for obinutuzumab (Gazyva®) for the treatment of ...